Hazardous Materials Packaging and Labeling

The contract requires the packaging and labeling of Dibucaine Ointment in strict adherence to military and federal hazardous material regulations, specifically conforming to MIL-STD-129 and TQ Requirement IP025, ensuring all materials meet the rigorous standards for handling, marking, and documenting hazardous pharmaceutical products within the defense supply chain. This subcontract is part of a broader effort by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA to maintain operational readiness by securing properly labeled and compliant medical supplies for deployment and use in military operations. The work must be performed under the place of performance designated as FPO with a zip code of 34089, and all deliverables must align with the North American Industry Classification System code 325998, which pertains to other pharmaceutical and medicine manufacturing. Responses to this solicitation are due by July 28, 2026, and the posting date is July 22, 2026, indicating a very limited window for submission. The contract is classified as a subcontract and does not specify a set-aside type, meaning it is open to eligible contractors without preference or restriction. All parties must ensure full compliance with hazardous material protocols and documentation requirements to avoid rejection or non-compliance penalties.